{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:22:13Z","timestamp":1781306533861,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04695-9","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:21:14Z","timestamp":1753939274000},"page":"391-406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating less-invasive strategies for localized prostate cancer: a comparative meta-analysis on high-intensity focused ultrasound versus radical prostatectomy"],"prefix":"10.1007","volume":"58","author":[{"given":"Henrique L.","family":"Lepine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio C.","family":"Vicentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiano Machado","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda M.","family":"Llata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Bessa","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo O.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Maur\u00edcio","family":"Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Carlos","family":"Nahas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo Alves","family":"Ribeiro-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Vin\u00edcius","family":"Suartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"9","key":"4695_CR1","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.ejca.2013.09.002","volume":"51","author":"M Arnold","year":"2015","unstructured":"Arnold M, Karim-Kos HE, Coebergh JW et al (2015) Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory. Eur J Cancer 51(9):1164\u20131187. https:\/\/doi.org\/10.1016\/j.ejca.2013.09.002","journal-title":"Eur J Cancer"},{"issue":"4","key":"4695_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3322\/CA.2008.0002","volume":"58","author":"MD Michaelson","year":"2008","unstructured":"Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR (2008) Management of complications of prostate cancer treatment. CA Cancer J Clin 58(4):196\u2013213. https:\/\/doi.org\/10.3322\/CA.2008.0002","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4695_CR3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.juro.2013.02.010","volume":"190","author":"S Th\u00fcroff","year":"2013","unstructured":"Th\u00fcroff S, Chaussy C (2013) Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years. J Urol 190(2):702\u2013710. https:\/\/doi.org\/10.1016\/j.juro.2013.02.010","journal-title":"J Urol"},{"issue":"5","key":"4695_CR4","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.eururo.2013.04.039","volume":"65","author":"S Crouzet","year":"2014","unstructured":"Crouzet S, Chapelon JY, Rouvi\u00e8re O et al (2014) Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Eur Urol 65(5):907\u2013914. https:\/\/doi.org\/10.1016\/j.eururo.2013.04.039","journal-title":"Eur Urol"},{"key":"4695_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.11.006","author":"G Ploussard","year":"2024","unstructured":"Ploussard G, Coloby P, Chevallier T et al (2024) Whole-gland or subtotal high-intensity focused ultrasound versus radical prostatectomy: the prospective, noninferiority, nonrandomized HIFI trial. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2024.11.006","journal-title":"Eur Urol"},{"issue":"2","key":"4695_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.prnil.2024.03.004","volume":"12","author":"J Nam","year":"2024","unstructured":"Nam J, Kim JK, Oh JJ et al (2024) Propensity score matched analysis of functional outcome in five thousand cases of robot-assisted radical prostatectomy versus high-intensity focused ultrasound. Prostate Int 12(2):104\u2013109. https:\/\/doi.org\/10.1016\/j.prnil.2024.03.004","journal-title":"Prostate Int"},{"issue":"2","key":"4695_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.euf.2019.11.014","volume":"7","author":"A Dosanjh","year":"2021","unstructured":"Dosanjh A, Harvey P, Baldwin S et al (2021) High-intensity focused ultrasound for the treatment of prostate cancer: a National Cohort Study focusing on the development of stricture and fistulae. Eur Urol Focus 7(2):340\u2013346. https:\/\/doi.org\/10.1016\/j.euf.2019.11.014","journal-title":"Eur Urol Focus"},{"key":"4695_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ctrv.2018.03.005","volume":"66","author":"M \u00c1vila","year":"2018","unstructured":"\u00c1vila M, Patel L, L\u00f3pez S et al (2018) Patient-reported outcomes after treatment for clinically localized prostate cancer: a systematic review and meta-analysis. Cancer Treat Rev 66:23\u201344. https:\/\/doi.org\/10.1016\/j.ctrv.2018.03.005","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"4695_CR9","doi-asserted-by":"publisher","first-page":"17019","DOI":"10.1038\/s41598-024-67592-8","volume":"14","author":"A Teramoto","year":"2024","unstructured":"Teramoto A, Sakamaki K, Shoji S, Uemura K (2024) Win ratio analysis of short-term clinical outcomes of focal therapy and robot-assisted radical prostatectomy for the patients with localized prostate cancer. Sci Rep 14(1):17019. https:\/\/doi.org\/10.1038\/s41598-024-67592-8","journal-title":"Sci Rep"},{"issue":"1","key":"4695_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/13696998.2023.2251849","volume":"26","author":"D Reddy","year":"2023","unstructured":"Reddy D, van Son M, Peters M et al (2023) Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis. J Med Econ 26(1):1099\u20131107. https:\/\/doi.org\/10.1080\/13696998.2023.2251849","journal-title":"J Med Econ"},{"key":"4695_CR11","doi-asserted-by":"publisher","unstructured":"Kakehi Y, Sugimoto M, Taoka R; committee for establishment of the evidenced-based clinical practice guideline for prostate cancer of the Japanese Urological Association (2017) Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition). Int J Urol 24(9):648\u2013666. https:\/\/doi.org\/10.1111\/iju.13380","DOI":"10.1111\/iju.13380"},{"issue":"3","key":"4695_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med 18(3):e1003583. https:\/\/doi.org\/10.1371\/journal.pmed.1003583","journal-title":"PLoS Med"},{"key":"4695_CR13","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"4695_CR14","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"1","key":"4695_CR15","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1186\/s40064-016-3584-4","volume":"5","author":"PH Chiang","year":"2016","unstructured":"Chiang PH, Liu YY (2016) Comparisons of oncological and functional outcomes among radical retropubic prostatectomy, high dose rate brachytherapy, cryoablation and high-intensity focused ultrasound for localized prostate cancer. Springerplus 5(1):1905. https:\/\/doi.org\/10.1186\/s40064-016-3584-4","journal-title":"Springerplus"},{"issue":"10","key":"4695_CR16","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00345-018-2613-z","volume":"37","author":"B Rosenhammer","year":"2019","unstructured":"Rosenhammer B, Ganzer R, Zeman F et al (2019) Oncological long-term outcome of whole gland HIFU and open radical prostatectomy: a comparative analysis. World J Urol 37(10):2073\u20132080. https:\/\/doi.org\/10.1007\/s00345-018-2613-z","journal-title":"World J Urol"},{"issue":"2","key":"4695_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/jpm12020251","volume":"12","author":"\u0141 Nyk","year":"2022","unstructured":"Nyk \u0141, Michalak W, Szempli\u0144ski S et al (2022) High-intensity focused-ultrasound focal therapy versus laparoscopic radical prostatectomy: a comparison of oncological and functional outcomes in low- and intermediate-risk prostate cancer patients. J Pers Med. 12(2):251. https:\/\/doi.org\/10.3390\/jpm12020251","journal-title":"J Pers Med."},{"issue":"4","key":"4695_CR18","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41391-021-00369-6","volume":"24","author":"MJ van Son","year":"2021","unstructured":"van Son MJ, Peters M, Reddy D et al (2021) Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control. Prostate Cancer Prostatic Dis 24(4):1120\u20131128. https:\/\/doi.org\/10.1038\/s41391-021-00369-6","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"Suppl 1","key":"4695_CR19","doi-asserted-by":"publisher","first-page":"O56","DOI":"10.1186\/2050-5736-3-S1-O56","volume":"3","author":"A Gelet","year":"2015","unstructured":"Gelet A, Crouzet S, Rouviere O, Chapelon JY, Rabilloud M (2015) Radical prostatectomy versus high intensity focused ultrasound for localized prostate cancer: a matched pair comparison. J Ther Ultrasound. 3(Suppl 1):O56. https:\/\/doi.org\/10.1186\/2050-5736-3-S1-O56","journal-title":"J Ther Ultrasound."},{"issue":"1","key":"4695_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/end.2016.0702","volume":"31","author":"S Albisinni","year":"2017","unstructured":"Albisinni S, Aoun F, Bellucci S et al (2017) Comparing high-intensity focal ultrasound hemiablation to robotic radical prostatectomy in the management of unilateral prostate cancer: a matched-pair analysis. J Endourol 31(1):14\u201319. https:\/\/doi.org\/10.1089\/end.2016.0702","journal-title":"J Endourol"},{"issue":"1","key":"4695_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.juro.2017.08.076","volume":"199","author":"S Garcia-Barreras","year":"2018","unstructured":"Garcia-Barreras S, Sanchez-Salas R, Sivaraman A et al (2018) Comparative analysis of partial gland ablation and radical prostatectomy to treat low and intermediate risk prostate cancer: oncologic and functional outcomes. J Urol 199(1):140\u2013146. https:\/\/doi.org\/10.1016\/j.juro.2017.08.076","journal-title":"J Urol"},{"issue":"3","key":"4695_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.prnil.2022.12.001","volume":"11","author":"G Jung","year":"2023","unstructured":"Jung G, Kim JK, Oh JJ et al (2023) Partial gland ablation using high-intensity focused ultrasound versus robot-assisted radical prostatectomy: a propensity score-matched study. Prostate Int 11(3):134\u2013138. https:\/\/doi.org\/10.1016\/j.prnil.2022.12.001","journal-title":"Prostate Int"},{"issue":"2","key":"4695_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41391-020-00315-y","volume":"24","author":"TT Shah","year":"2021","unstructured":"Shah TT, Reddy D, Peters M et al (2021) Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study. Prostate Cancer Prostatic Dis 24(2):567\u2013574. https:\/\/doi.org\/10.1038\/s41391-020-00315-y","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"4695_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejso.2017.11.008","volume":"44","author":"P Capogrosso","year":"2018","unstructured":"Capogrosso P, Barret E, Sanchez-Salas R et al (2018) Oncological and functional outcomes of elderly men treated with HIFU vs. minimally invasive radical prostatectomy: a propensity score analysis. Eur J Surg Oncol 44(1):185\u2013191. https:\/\/doi.org\/10.1016\/j.ejso.2017.11.008","journal-title":"Eur J Surg Oncol"},{"issue":"Supplement 4","key":"4695_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003341.15","volume":"209","author":"E Baco","year":"2023","unstructured":"Baco E, Alemu T, Rud E (2023) MP73\u201315 Comparison of postoperative complications between focal ablation and radical prostatectomy for intermediate-risk prostate cancer: the FARP randomized trial. J Urol 209(Supplement 4):e1041. https:\/\/doi.org\/10.1097\/JU.0000000000003341.15","journal-title":"J Urol"},{"issue":"52","key":"4695_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22520","volume":"22","author":"FC Hamdy","year":"2018","unstructured":"Hamdy FC, Elliott D, le Conte S et al (2018) Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT. Health Technol Assess 22(52):1\u201396. https:\/\/doi.org\/10.3310\/hta22520","journal-title":"Health Technol Assess"},{"issue":"1","key":"4695_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11701-024-02123-1","volume":"18","author":"CJ Wang","year":"2024","unstructured":"Wang CJ, Pang CC, Qin J et al (2024) Comparative study of HIFU partial gland ablation and robot-assisted radical prostatectomy for localized prostate cancer: an evidence-based approach. J Robot Surg 18(1):367. https:\/\/doi.org\/10.1007\/s11701-024-02123-1","journal-title":"J Robot Surg"},{"issue":"1","key":"4695_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","volume":"81","author":"JS Hopstaken","year":"2022","unstructured":"Hopstaken JS, Bomers JGR, Sedelaar MJP, Valerio M, F\u00fctterer JJ, Rovers MM (2022) An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years? Eur Urol 81(1):5\u201333. https:\/\/doi.org\/10.1016\/j.eururo.2021.08.005","journal-title":"Eur Urol"},{"issue":"4","key":"4695_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.eururo.2022.01.005","volume":"81","author":"D Reddy","year":"2022","unstructured":"Reddy D, Peters M, Shah TT et al (2022) Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience. Eur Urol 81(4):407\u2013413. https:\/\/doi.org\/10.1016\/j.eururo.2022.01.005","journal-title":"Eur Urol"},{"issue":"2","key":"4695_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1590\/s1677-55382011000200008","volume":"37","author":"AB El Fegoun","year":"2011","unstructured":"El Fegoun AB, Barret E, Prapotnich D et al (2011) Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up. Int Braz J Urol 37(2):213\u2013222. https:\/\/doi.org\/10.1590\/s1677-55382011000200008","journal-title":"Int Braz J Urol"},{"issue":"6","key":"4695_CR31","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S1470-2045(12)70121-3","volume":"13","author":"HU Ahmed","year":"2012","unstructured":"Ahmed HU, Hindley RG, Dickinson L, Freeman A, Kirkham AP, Sahu M, Scott R, Allen C, Van der Meulen J, Emberton M (2012) Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol 13(6):622\u2013632. https:\/\/doi.org\/10.1016\/S1470-2045(12)70121-3","journal-title":"Lancet Oncol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04695-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04695-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04695-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:21:46Z","timestamp":1770042106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04695-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["4695"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04695-9","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not available.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}